CSIMarket



Pfizer Inc  (PFE)
Other Ticker:  
 
 

PFE's EPS Net Growth by Quarter and Year

Pfizer Inc's EPS Net results by quarter and year




PFE EPS Net (in $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter January - 0.59 0.11 -0.06
III Quarter October - 1.42 0.39 1.36
II Quarter July - 0.98 0.61 0.89
I Quarter April 1.37 0.86 0.61 0.68
FY   1.37 3.85 1.72 2.87



PFE EPS Net first quarter 2022 Y/Y Growth Comment
Pfizer Inc achieved in the first quarter 2022, above Company average EPS Net rise of 59.3% year on year, to $ 1.37 .

Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 12 other companies have achieved higher EPS Net growth. While Pfizer Inc' s EPS Net jump of 59.3% ranks overall at the positon no. 462 in the first quarter 2022.




PFE EPS Net ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter January - 436.36 % - -
III Quarter October - 264.1 % -71.32 % 97.1 %
II Quarter July - 60.66 % -31.46 % 36.92 %
I Quarter April 59.3 % 40.98 % -10.29 % 15.25 %
FY   - 123.84 % -40.07 % 54.3 %

Financial Statements
Pfizer Inc's first quarter 2022 EPS Net $ 1.37 PFE's Income Statement
Pfizer Inc's first quarter 2021 EPS Net $ 0.86 Quarterly PFE's Income Statement
New: More PFE's historic EPS Net Growth >>


PFE EPS Net (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter January - -58.45 % -71.79 % -
III Quarter October - 44.9 % -36.07 % 52.81 %
II Quarter July - 13.95 % 0 % 30.88 %
I Quarter April 132.2 % 681.82 % - -
FY (Year on Year)   - 123.84 % -40.07 % 54.3 %




EPS Net first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #13
Healthcare Sector #35
Overall #462

EPS Net Y/Y Growth Statistics
High Average Low
180.67 % 5.24 % -58.9 %
(Dec 31 2017)   (Dec 31 2018)
EPS Net first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #13
Healthcare Sector #35
Overall #462
EPS Net Y/Y Growth Statistics
High Average Low
180.67 % 5.24 % -58.9 %
(Dec 31 2017)   (Dec 31 2018)

EPS Net by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Pfizer Inc's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
1075 % 62.41 % -89.47 %
(June 30. 2005)  


PFE's I. Quarter Q/Q EPS Net Comment
Pfizer Inc achieved in the I. Quarter 2022 above company average sequential EPS Net doubling of 132.2%, to $ 1.37 , from $0.59 in the forth quarter.

Within Major Pharmaceutical Preparations industry 4 other companies have achieved higher EPS Net quarter on quarter growth. While Pfizer Inc's EPS Net growth quarter on quarter, overall rank is 200.


EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #5
Healthcare Sector #14
Overall #200
EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #5
Healthcare Sector #14
Overall #200
EPS Net Q/Q Growth Statistics
High Average Low
1075 % 62.41 % -89.47 %
(June 30. 2005)  


PFE's I. Quarter Q/Q EPS Net Comment
Pfizer Inc achieved in the I. Quarter 2022 above company average sequential EPS Net doubling of 132.2%, to $ 1.37 , from $0.59 in the forth quarter.

Within Major Pharmaceutical Preparations industry 4 other companies have achieved higher EPS Net quarter on quarter growth. While Pfizer Inc's EPS Net growth quarter on quarter, overall rank is 200.


Pfizer Inc's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Apr 03 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Oct 03 2021)
12 Months Ending
(Jul 04 2021)
12 Months Ending
(Apr 04 2021)
Cumulative EPS Net 12 Months Ending $ 4.36 $ 3.85 $ 3.37 $ 2.34 $ 1.97
Y / Y EPS Net Growth (TTM) 121.79 % 124.38 % 117.08 % -7.34 % -29.82 %
Year on Year EPS Net Growth Overall Ranking # 263 # 406 # 334 # 1385 # 1408
Seqeuential EPS Net Change (TTM) 13.25 % 14.36 % 44.11 % 18.83 % 14.58 %
Seq. EPS Net Growth (TTM) Overall Ranking # 462 # 652 # 248 # 820 # 869




Cumulative EPS Net growth Comment
Assuming the Pfizer Inc's fiscal year would have ended in Apr 03 2022, Pfizer Inc would have reprted above average annual EPS Net surge of 121.79% year on year, of $ 4 .
This marks a slow-down of the companys growth trends and from the 124.38% surge in Dec 31 2021.

Within the Healthcare sector 22 other companies have achieved higher trailing twelve month EPS Net growth. While Total ranking has impoved so far to 263, from total ranking in previous quarter at 406.

EPS Net TTM Q/Q Growth Statistics
High Average Low
180.67 %
5.24 %
-58.9 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 13
Healthcare Sector # 23
Overall # 263

EPS Net TTM Y/Y Growth Statistics
High Average Low
297.37 %
25.3 %
-56.59 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 13
Sector # 35
S&P 500 # 462
Cumulative EPS Net growth Comment
Assuming the Pfizer Inc's fiscal year would have ended in Apr 03 2022, Pfizer Inc would have reprted above average annual EPS Net surge of 121.79% year on year, of $ 4 .
This marks a slow-down of the companys growth trends and from the 124.38% surge in Dec 31 2021.

Within the Healthcare sector 22 other companies have achieved higher trailing twelve month EPS Net growth. While Total ranking has impoved so far to 263, from total ranking in previous quarter at 406.

EPS Net TTM Q/Q Growth Statistics
High Average Low
180.67 %
5.24 %
-58.9 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 13
Healthcare Sector # 23
Overall # 263

EPS Net TTM Y/Y Growth Statistics
High Average Low
297.37 %
25.3 %
-56.59 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 13
Sector # 35
S&P 500 # 462




Other EPS Net Growth
Major Pharmaceutical Preparations Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
PFE's EPS Net Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for PFE's Competitors
EPS Net Growth for Pfizer Inc's Suppliers
EPS Net Growth for PFE's Customers

You may also want to know
PFE's Annual Growth Rates PFE's Profitability Ratios PFE's Asset Turnover Ratio PFE's Dividend Growth
PFE's Roe PFE's Valuation Ratios PFE's Financial Strength Ratios PFE's Dividend Payout Ratio
PFE's Roa PFE's Inventory Turnover Ratio PFE's Growth Rates PFE's Dividend Comparisons



Companies with similar EPS Net surge for the quarter ending Apr 03 2022 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Apr 03 2022
Staar Surgical Co90.00%$ 90.000 
Pfizer Inc59.30%$ 59.302 
Agilent Technologies inc.30.00%$ 30.000 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NCRE's Profile

Stock Price

NCRE's Financials

Business Description

Fundamentals

Charts & Quotes

NCRE's News

Suppliers

NCRE's Competitors

Customers & Markets

Economic Indicators

NCRE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071